What is Solid Biosciences Inc.'s price / sales?

Solid Biosciences Inc. (SLDB) reported price / sales of 13× in Q4 2022.

How has Solid Biosciences Inc.'s price / sales changed year-over-year?

Solid Biosciences Inc.'s price / sales decreased by 8.4% year-over-year, from 14.2× to 13×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Solid Biosciences Inc. SLDB Price / sales

Discontinued — last reported Q4 '22

Price / sales at other companies

Sarepta Therapeutics, Inc.SRPT

1×—

BiogenBIIB

2.7×+0.7×

Neurocrine BiosciencesNBIX

4.3×-0.3×

InsmedINSM

43×+6.8×

Taysha Gene Therapies, Inc.TSHA

171.9×+132×

uniQureQURE

56.5×+28.1×

Other financials

Income statement

See full

Revenue$2.0M-40.6%

Operating income-$57.3M-43.1%

Net income-$56.7M-44.4%

EPS (diluted)-$0.52+11.9%

Balance sheet

See full

Cash & equivalents$297.1M+41.1%

Total debt$20.7M-12.5%

Total equity$374.1M+27.1%

Total assets$422.9M+23.0%

Cash flow

See full

Operating cash flow-$47.2M-48.3%

CapEx$165.0K+31.0%

Free cash flow-$47.4M-48.2%

Valuation

See full

Market cap$910.66M+145%

Enterprise value$634.23M+244%

Profitability

See full

Operating margin-1,315.2%-4,060pp

Net margin-1,062.3%-251,151pp

FCF margin-1,247.7%-9,569pp

Returns & leverage

See full

Return on equity-57.4%+2.2pp

Debt / equity0.1×0.0×

Current ratio13.1×+2.2×

Where this comes from

Calculated from Solid Biosciences Inc.’s reported figures.

market cap/total revenue=13×

Based on the most recent quarter.

The official record: Solid Biosciences Inc.’s 10-K, filed March 13, 2024, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solid Biosciences Inc.'s price / sales?: Solid Biosciences Inc. (SLDB) reported price / sales of 13× in Q4 2022.
How has Solid Biosciences Inc.'s price / sales changed year-over-year?: Solid Biosciences Inc.'s price / sales decreased by 8.4% year-over-year, from 14.2× to 13×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.